Kestra Medical Technologies, Ltd. Common Stock (KMTS) support and resistance · rev $95.1M
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
This page maps Kestra Medical Technologies, Ltd. Common Stock (KMTS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
KMTS currently screens at market cap $1.24B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new KMTS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the KMTS quote page for the session range and the stock page for the full model.
Not investment advice.